Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy, and help clarify the individual assessment of risk and benefit. This new information may be reassuring to millions of women who currently take, or are appropriate candidates for, estrogen-alone therapy. |
Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy. |